OBJECTIVE: The series of papers in this issue was developed to examine the use of health technology assessment in policies toward prevention-specifically toward mass screening-in European countries. The papers actually examined three screening strategies: mammography screening for breast cancer, prostate-specific antigen screening for prostate cancer, and routine ultrasound in normal pregnancy. METHODS: Papers were sought from the member states of the European Union, plus Switzerland. Ultimately, nine acceptable papers were received, and were reviewed, revised, and edited. RESULTS: Screening is an accepted strategy in many countries for reducing the burden of disease through early detection and intervention. In part, this is because of successful screening programs that have been evaluated and implemented in many countries. At the same time, unevaluated and even useless and harmful screening programs-unjustified medically or economically-are widespread. Health technology assessment could help ...
The objectives of this paper are to describe the status and development of health technology regulation with regard to coverage decisions and utilization, and to analyze the current situation of health technology assessment (HTA) in Germany. The relevant literature for controlling health technologies was identified by searching the literature and databases and through personal contacts. The literature was analyzed with regard to the different sectors in the healthcare system. For the analysis of the current state of HTA in Germany, a national survey was carried out. In addition, the names of topics under assessment were collected. The results show that coverage decisions in the ambulatory sector appear to be much more regulated than those in the inpatient sector. The same is true for diffusion and usage of technologies. The strict separation of the hospital and the ambulatory care sector in Germany constitutes a barrier to regulation and to making HTA an effective instrument in Germany. Until ...
While the Health Technology Assessment (HTA) community has acknowledged the importance of public and consumer involvement in the HTA process, very few studies have examined how technology-related findings may be reported by the media to the broader public. This paper compares the content of press articles with the content of three Canadian HTA reports that respectively assess electroconvulsive therapy, first-trimester prenatal screening for Down syndrome, and prostate-specific antigen screening for prostate cancer. We qualitatively and quantitatively analyzed 186 press articles addressing the same technologies. Our results show that beyond stylistic emphasis, there is an important overlap between media coverage of these technologies and the content of HTA reports. Findings also highlight shared interests on which both researchers and journalists could build to enhance the communication of health information to the public ...
Health care policy-makers throughout Europe seek to improve the health status of their citizens through the delivery of health services. Health policy thus aims at improving the performance and health outcomes within sustainable health systems.. Health technology assessment (HTA) contributes to the formulation of such health policy by providing evidence-based information to those who make policies and decide on the coverage and usage of health technologies. However, establishing links between HTA and policy-making poses challenges to both producers and users of HTA - and there is a potential to improve the responsiveness of HTA to the needs of policy-makers to achieve the desired goal for HTA of a larger policy input role.. This book gives an overview of the relationship between HTA and health policy in Europe by:. ...
OBJECTIVES: The aim of this study was to review and compare current health technology assessment (HTA) activities for medical devices across non-European Union HTA agencies. METHODS: HTA activities for medical devices were evaluated from three perspectives: organizational structure, processes, and methods. Agencies were primarily selected upon membership of existing HTA networks. The data collection was performed in two stages: stage 1-agency Web-site assessment using a standardized questionnaire, followed by review and validation of the collected data by a representative of the agency; and stage 2-semi-structured telephone interviews with key informants of a sub-sample of agencies. RESULTS: In total, thirty-six HTA agencies across twenty non-EU countries assessing medical devices were included. Twenty-seven of thirty-six (75 percent) agencies were judged at stage 1 to have adopted HTA-specific approaches for medical devices (MD-specific agencies) that were largely organizational or procedural. ...
Get this from a library! Gene Therapy : International Regulatory and Health Technology Assessment (HTA) Activities and Reimbursement Status. [Tara Cowling; Sarah Jones;]
We review the various aspects of health technology assessment in osteoporosis, including epidemiology and burden of disease, and assessment of the cost-effectiveness of recent advances in the treatmen
The Adelaide Health Technology Assessment (AHTA) conduct systematic reviews on health and interventions and produce guidelines to provide a rational basis for health care decision-making.
Health Technology Assessment 2005; Vol. 9: No. 17 Immediate angioplasty for acute myocardial infarction Feedback The HTA Programme and the authors would like to know your views about this report. The Correspondence Page on the HTA website (http://www.ncchta.org) is a convenient way to publish your comments. If you prefer, you can send your comments to the address below, telling us whether you would like us to transfer them to the website. We look forward to hearing from you. Health Technology Assessment 2005; Vol. 9: No. 17 Clinical effectiveness and costeffectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation D Hartwell, J Colquitt, E Loveman, AJ Clegg, H Brodin, N Waugh, P Royle, P Davidson, L Vale and L MacKenzie May 2005 The National Coordinating Centre for Health Technology Assessment, Mailpoint 728, Boldrewood, University of Southampton, Southampton, SO16 7PX, UK. Fax: +44 (0) 23 8059 5639 Email: [email protected] ...
I volumi e gli articoli citati sono in ordine cronologico, in modo da mettere in evidenza quelli più recenti, in cima allelenco.. Battista RN, Hodge MJ. The evolving paradigm of health technology assessment: reflections for the millennium. CMAJ 1999; 160: 1464-7.. Jonsson E, Banta D. Management of health technologies: an international view. BMJ 1999; 319: 1293.. Rosen R, Gabbey J. Linking health technology assessment to practice. BMJ 1999; 319: 1-3.. Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998; 317: 465-8.. Goodman CS. Technology assessment: A tool for technology management and improved patient outcomes. USA: The Lewin Group, 1998.. Heitman E. Ethical issues in technology assessment. Conceptual categories and procedural considerations. Int J Technol Assess Health Care 1998; 14 (3): 544-66.. Sheldon TA, Guyatt GH, Haines A. Getting research ...
The objective of this paper is to evaluate the Corn Technology Assessment project from the viewpoint of its being a pilot project of the broader-type of commodity-specific technology assessment. More specifically, the discussion will center on : a definition of TA; objectives of the TA; delineation of production systems (by commodity or by technology); a framework of analysis; and the process of identifying specific technologies. Sundquist, W. Burt; Menz, Kenneth M.; Neumeyer, Catherine F.
I returned to ScHARR in January 2010 after spending three years working on NICE Clinical Guidelines. I started in November 2006 as Senior Health Economist at the National Collaborating Centre for Nursing and Supportive Care which developed Clinical Guidelines for NICE. When this centre was merged with three others to form the National Clinical Guideline Centre (NCGC) in April 2009, I joined the NCGC as Health Economics Lead.. Prior to this period, I was a cost-effectiveness modeller within the HEDS section at ScHARR where I worked on NICE Technology Appraisals, NICE Clinical Guidelines, Health Technology Assessments and consultancy projects for the pharmaceutical industry.. I am currently Deputy Director of the NICE Decision Support Unit (DSU). The DSU is commissioned by The National Institute for Health and Clinical Excellence (NICE) to provide a research and training resource to support the Institutes Technology Appraisal Programme.. ...
Health Technology Assessment Cochlear Implants: Bilateral versus Unilateral Final Evidence Report April 17, 2013 Health Technology Assessment Program (HTA) Washington State Health Care Authority PO Box
The appraisal committee considered the evidence on the clinical effectiveness of DES in the treatment of coronary heart disease (CHD). The meta-analysis of the clinical trials, conducted by the assessment group,3 showed that the use of DES reduced the rate of revascularisation in the target lesions and the target vessels, at all follow-up time points up to three years, compared with bare-metal stents (BMS). This reduced rate of revascularisation was not, however, accompanied by a reduction in mortality. The committee additionally took into account the ongoing international debate regarding the possible adverse effects of DES on the longer-term risks of myocardial infarction and mortality. It accepted the findings of the Food and Drug Administration review4 and agreed that the most reasonable view at present is that DES conferred no statistically significant benefits or harms in mortality or acute myocardial infarction (MI) rates in the longer term over BMS, when used within their indications for ...
Introduction: As the pace of health technology innovations increases greater pressure is placed on HTA agencies to review and make recommendations promptly. One response to this pressure is the use of Rapid Reviews (RRs). As part of the HTA system RRs can support decision making in an environment with increasing competing demands by synthesising evidence to support informed decisions in a timely manner, without sacrificing scientific rigor. Since 2009 all new drugs in Ireland are first subject to a RR. After which a full HTA may or may not be required. The objective of this study is to examine what factors determine the outcome of a rapid review, i.e. if a full HTA is recommended or not. Methods: Data on drug evaluations from 2009 to 2016 were extracted from the NCPE websites. A logit regression was employed to determine the factors influencing the outcome of the rapid review, i.e. the recommendation for a full HTA. Results: All drugs for which a RR only was required were recommended for ...
It must be emphasised that the output from NICE and HTBS will be advice on clinical- and cost-effectiveness and not on need, budgetary priority or affordability. Assessments will certainly inform the process of rational and equitable distribution of resources, but they are not about what a health care provider should afford or can afford, nor are they about assessing population needs or prioritising these against available resources. However, regardless of questions of priority and affordability, any reasonable person would surely not condone the provision of treatments that were either only equivocally beneficial or where the benefit per £ (sterling), or per hour of clinical time taken from some other activity, was less than an alternative. Advising on the degree of real benefit and value for money should, therefore, be seen as an aid to the evidence-based, equitable distribution of limited resources but should not be seen as stumbling into rationing (Smith, 2000).. Health technology ...
A multi-disciplinary field of policy analysis that examines the medical, economic, social and ethical implications of medical technology in healthcare.
TY - JOUR. T1 - Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis. AU - Westwood, Marie. AU - Ramaekers, Bram. AU - Lang, Shona. AU - Grimm, Sabine. AU - Deshpande, Sohan. AU - de Kock, Shelley. AU - Armstrong, Nigel. AU - Joore, Manuela. AU - Kleijnen, Jos. PY - 2018/8/1. Y1 - 2018/8/1. KW - MALIGNANCY ALGORITHM ROMA. KW - IOTA SIMPLE RULES. KW - MULTICENTER EXTERNAL VALIDATION. KW - ULTRASOUND-BASED RULES. KW - ADNEXAL MASSES. KW - PELVIC MASS. KW - DIAGNOSTIC-ACCURACY. KW - INDEX RMI. KW - PREOPERATIVE DIAGNOSIS. KW - POSTMENOPAUSAL WOMEN. KW - DIFFERENTIAL-DIAGNOSIS. KW - POSTOPERATIVE MORTALITY. KW - MENOPAUSAL STATUS. U2 - 10.3310/hta22440. DO - 10.3310/hta22440. M3 - Review article. VL - 22. SP - 1. EP - 266. JO - Health Technology Assessment. JF - Health Technology Assessment. SN - 1366-5278. IS - 44. ER - ...
Patients and patient groups need to have good knowledge about their own disease, its management and treatment and how these work for them. This is in a broad group of patients if they are actively participating in decision making committees as representatives. They may also need some education and training about specific issues relevant to their role, the expectations of them, and HTA processes relevant to their engagement.. Preparation may include education on the role they are to play and what they can expect, the role of the event or committee they are engaging in, background information on the HTA organisation, processes and where to find the information, support and knowledge they need to actively participate.. Patient representatives on advisory committees are required to have background knowledge in evidence based medicine and consumer matters, to be conversant with relevant technical matters for the committee, be able to effectively represent the views of those who they represent (unless ...
The inspiration for the present assessment of the nutritional care of medical patients is puzzlement about the divide that exists between the theoretical knowledge about the importance of the diet for ill persons, and the common failure to incorporate nutritional aspects in the treatment and care of the patients. The purpose is to clarify existing problems in the nutritional care of Danish medical inpatients, to elucidate how the nutritional care for these inpatients can be improved, and to analyse the costs of this improvement. Qualitative and quantitative methods are deployed to outline how nutritional care of medical inpatients is performed at three Danish hospitals. The practices observed are compared with official recommendations for nutritional care of inpatients. Factors extraneous and counterproductive to optimal nutritional care are identified from the perspectives of patients and professional staff. A review of the literature illustrates the potential for optimal nutritional care. A health
PubMed Central Canada (PMC Canada) provides free access to a stable and permanent online digital archive of full-text, peer-reviewed health and life sciences research publications. It builds on PubMed Central (PMC), the U.S. National Institutes of Health (NIH) free digital archive of biomedical and life sciences journal literature and is a member of the broader PMC International (PMCI) network of e-repositories.
An integrated multi-criteria decision making methodology for health technology assessment, European J. of Industrial Engineering, Vol:12 No:4 (2018) *Karakaya, E., Tozan, H., Karataş, M., and Bartolacci, M.R., Scenario-based Cycle Time Comparison of Cellular Transport Systems with Conventional Warehouse Systems, G.J. of Research in Engineering, Volume 17, No:2 (2017).* Defining Criteria Weights by AHP In Health Technology Assessment, Value in Health, Vol:20, No:9,(2017) 698 *Karatas M., Razi N., Tozan H., A multi-criteria assessment of the p-median, maximal coverage and p-center location models, TV-TG, Vol:24 No:2 (2017) 399-407 *Oztrurk. N, Tozan H., A fuzzy-based decision support model for selecting the best dialyser flux in haemodialysis Journal of Healthcare Engineering, Vol:6, No:3, (2015) 303-324., *Ceylan Z., Bulkan S., Tozan H., Single and Multi-Period Inventory Control Models, Journal of Eng. Sci. and Design, Vol:5 No:2(2017) 441-455. *Karatas M., Razi N., Tozan H., A ...
An integrated multi-criteria decision making methodology for health technology assessment, European J. of Industrial Engineering, Vol:12 No:4 (2018) *Karakaya, E., Tozan, H., Karataş, M., and Bartolacci, M.R., Scenario-based Cycle Time Comparison of Cellular Transport Systems with Conventional Warehouse Systems, G.J. of Research in Engineering, Volume 17, No:2 (2017).* Defining Criteria Weights by AHP In Health Technology Assessment, Value in Health, Vol:20, No:9,(2017) 698 *Karatas M., Razi N., Tozan H., A multi-criteria assessment of the p-median, maximal coverage and p-center location models, TV-TG, Vol:24 No:2 (2017) 399-407 *Oztrurk. N, Tozan H., A fuzzy-based decision support model for selecting the best dialyser flux in haemodialysis Journal of Healthcare Engineering, Vol:6, No:3, (2015) 303-324., *Ceylan Z., Bulkan S., Tozan H., Single and Multi-Period Inventory Control Models, Journal of Eng. Sci. and Design, Vol:5 No:2(2017) 441-455. *Karatas M., Razi N., Tozan H., A ...
CMS, A list of Technology Assessments that are used by CMS to inform its national coverage decisions for the Medicare program and provide information to Medicare carriers
This document-Part II, Onboard Guidance, Navigation, and Control-is the second in a series of three technology assessments evaluating the capabilities and technologies needed for future missions pursuing SMD PSDs scientific goals.
New or updated reports from the Congressional Research Service obtained by Secrecy News include the following.. Carbon Capture: A Technology Assessment, October 21, 2013. Social Security: What Would Happen If the Trust Funds Ran Out?, October 21, 2013. Video Relay Service: Program Funding and Reform, October 22, 2013. Mandatory Minimum Sentencing: Federal Aggravated Identity Theft, October 22, 2013. Hydraulic Fracturing: Selected Legal Issues, October 22, 2013. Federal Financial Reporting: An Overview, October 22, 2013. Fatherhood Initiatives: Connecting Fathers to Their Children, October 22, 2013. Promoting Global Internet Freedom: Policy and Technology, October 22, 2013. The G-20 and International Economic Cooperation: Background and Implications for Congress, October 23, 2013. U.S. Strategic Nuclear Forces: Background, Developments, and Issues, October 22, 2013. ...
Information about the Dairy Australia Technology Assessment (DATA) Scheme, which is designed to enhance the way the Australian dairy processing sector evaluates and screens emerging technologies.
The development of a technique which can be used to categorize and select industries for the NIOSH Control Technology Assessment effort is discussed. The development of a technique utilizing data from government and business publications is described. The two methodologies that could be employed to modify an initial industry classification and priority based on government and business publications
Health Technology Appraisals is an important part of Campaigning and Advocacy within Leukaemia CARE, working for patients with patients. Find out more here
Minister Helen McEntee & patient representative, Canice Hayes, member of ProACT research panel. Commenting on its significance, the newly appointed Minister McEntee said: Supporting older people and the challenges they face in later years is a priority for us in Government. ProACT is just one example of how this can be achieved by providing a unified approach to integrated care, centred on the patient at home with support from caregivers, social care workers, community based GPs, pharmacists and hospital based clinicians. I am delighted to be launching this project today as it clearly will help people to remain in their own homes in the community as they grow older.. Provost and President, Dr Patrick Prendergast of Trinity College said: Addressing the challenges of ageing is a priority for Trinity researchers. ProACT is a prime example of how important this research is for the benefit of all in society. It brings together clinical and health research, data solutions and ICT that will lead ...
2012 - 2015 Cancer Research Aberdeen & North East Scotland (CRANES) Development of core outcomes for surgical management of localised prostate cancer to support decision-making by patients, clinicians and policy makers £176,903. 2012 - 2015 Health Technology Assessment Programme (HTA) Ablative therapy for men with localised prostate cancer £292,253. 2012 - 2013 NIHR HTA Systematic review and economic modelling of ablative therapy for men with localised prostate cancer £300,000. 2010 - 2013 NIHR HTA Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre placebo controlled randomised trial of a calcium channel blocker (nifedipine) and an alpha blocker (tamsulosin) (SUSPEND) £1,452,458. 2010 - 2011 NIHR HTA Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer £235,000. 2009 - 2012 ...
Title: Surface/Specialty Coil Devices and Gating Techniques in Magnetic Resonance Imaging.. Agency: Agency for Health Care Policy and Research/Center for Health Care Technology (Formerly, the Office of Health Technology Assessment).. Contact: Martin Erlichman, M.S., Senior Health Science Analyst.. Status: Technology Assessment: Published, 1990.. Language: English.. Primary Objective: Scientific evaluation of the safety and clinical effectiveness of surface and other specialty coil devices and gating techniques in conjunction with MRI procedures.. Methods Used: Synthesis of published literature and information solicited from Public Health Service agencies and professional societies and organizations.. Data Identification: English language journal articles and textbooks published between 1980 and 1988 available through the search capabilities of the National Library of Medicine. Key Words: MRI, Surface Coils, Gating, Respiratory Gating.. Study Selection: 19 studies contained information ...
NOAC is the term used to describe new drug treatments that are alternatives to warfarin, namely: dabigatran, rivaroxaban and apixaban. All three are the subject of NICE technology appraisal guidance and their licensed indications are referred to in the linked information. Atrial Fibrillation (AF). This is a link to the joint formulary.. Under each drug it has the clinical decision aid called Medicines for stroke prevention in AF. Patients and GPs can use to determine which oral anticoagulant option is most appropriate for an individual patient. It is important that patients make informed decisions about which medicine may be the best for them. Whilst NOACs are available to be prescribed as per NICE guidance, warfarin remains the first line treatment option; Clinicians should consider, with patients, the individuals and collectively the whole CCGs benefits and costs of using warfarin or a NOAC.. Venous Thrombo-Embolism. Pathway for new presentation of VTE - this is guidance for GPs about how to ...
NICE Publish Nintedanib Guidance on ILD-IN | The long awaited guidance on the use of Nintedanib to treat IPF has been published by NICE. Nintedanib for treating idiopathic pulmonary fibrosis NICE technology appraisal guidance [TA379] Published date: January 2016 Recommendations 1. Nintedanib is…
EVAR. The results of the £1.7 million EVAR trials, commissioned by the NHS Health Technology Assessment (HTA) programme, in the UK, and published in The Lancet journal, consist of two separate randomised controlled trials for patients fit for open repair (EVAR 1) or unfit/high risk (EVAR 2). The trials recruited a total 1,420 patients making it the largest study of its kind globally. The multi-centred trials are run from Charing Cross Hospital, Hammersmith Hospitals NHS Trust, Imperial College London in collaboration with another 41 centres nationwide. After witnessing the EVAR presentation, Professor Peter Littlejohns, Medical Director of the National Institute Clinical Excellence (NICE) said that if scientific work was always of such high quality, NICE could disband.. EVAR 1 was first to compare EVAR and open repair (OR) and has been successful in recruiting a large number of patients (1,082) and experts to take part before the new EVAR technique became the first choice procedure of surgeons ...
Health Technology Assessment 2001; Vol. 5: No. 32 Rapid review A rapid and systematic review of the clinical effectiveness and costeffectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in
NICE has published five technology appraisals and updated three on treatments for advanced renal cell carcinoma, osteoporosis, soft tissue sarcoma, and rheumatoid arthritis.
One evidence-based guideline was identified regarding the use of radiography to screen for scoliosis in children. No relevant health technology assessments, systematic reviews, meta-analyses, randomized controlled trials, or non-randomized studies were identified.. ...
ECRI is committed to protecting patients from unsafe and ineffective medical technologies and practices. We offer evidence-based research and health technology assessments; supply chain management solutions; patient safety, risk, and quality support; and consulting to healthcare organizations worldwide.
HTA Consulting is a Polish company with long-time experience, specialising in health technology assessment for drugs, medical devices and diagnostic methods in Poland and worldwide. We analyse, advise and train in the field of legislative and systemic solutions, pricing, designing and implementing research for health care organisations and private institutions.
HTA Consulting is a Polish company with long-time experience, specialising in health technology assessment for drugs, medical devices and diagnostic methods in Poland and worldwide. We analyse, advise and train in the field of legislative and systemic solutions, pricing, designing and implementing research for health care organisations and private institutions.
On March 28, 2017, CADTH published the fourth edition of the Guidelines for Economic Evaluation of Health Technologies: Canada, which set out the best practices for determining the economic value of health technologies. Canada Food, Drugs, Healthcare, Life Sciences Smart & Biggar/Fetherstonhaugh 1 Jun 2017
Review methods. MEDLINE, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Health Technology Assessments, and Web sites (1991 to Oct 2007) were searched for good-quality systematic reviews; 1 was selected. MEDLINE, CINAHL, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews (2002 to Feb 2010) were searched for English-language, randomized, controlled trials (RCTs) published after the selected systematic review and reporting intervention efficacy. MEDLINE and CINAHL (1992 to Feb 2010) were searched for trials reporting harms. 54 RCTs (n = 26 102) met the selection criteria: 19 (n = 7099) assessed multifactorial assessment and management programs, 18 (n = 3986) assessed exercise or physical therapy, 9 (n = 5809) evaluated vitamin D (daily oral dose range, 10 IU to 1000 IU; median, 800 IU), 4 (n = 1437) assessed vision correction procedures, 3 (n = 2348) assessed home-hazard modification, and 1 each assessed medication ...
The EESC believes that evidence based processes like Health Technology Assessment (HTA) that is a key driver for socio-economic growth and innovation in the Union can be achieved through cooperation between Member States at Union level aiming at a high protection of health for patients and ensuring the smooth functioning of an inclusive Single Market. It is concerned about the set timelines of implementation and especially the delayed application of three years and believes that for the benefit of the patients and cost-effectiveness this could be shortened. In order to achieve the promise of digital health and care, of which HTA is part, the involvement of civil society is crucial.. ...
The following figure outlines her core research themes and the relevant projects with a strong interest in clinical trials, diagnostic research, evidence synthesis and evidence based medicine. Her research work is largely collaborative with national and international partners.. She was awarded a PhD by the University of Birmingham for her work on Health Technology Assessment in Maternal and Perinatal Medicine. The output from the PhD directly led to 3 successful HTA grants (PREP, EMPIRE, and Pulse Ox) and NICE recommendations for tests in pre-eclampsia.. She is part of the core team at Womens Health Research Network at Barts and the London and involved in the training of researchers, development of the department and establishing links with other units in North East London through the newly founded Katherine Twining Network. It is a multidisciplinary collaborative Network of seven Trusts in North East London. The Network membership is composed of academics, R&D managers, professionals and ...
ORCID: 0000-0002-4250-5758, Grieve, R., Harrison, D., Harvey, S., Howell, D., Mythen, M., Sadique, Z., Smyth, D., Weinman, J., Welch, J. and Rowan, K. M. (2018). Psychological Outcomes following a nurse-led Preventative Psychological Intervention for critically ill patients (POPPI): protocol for a cluster-randomised clinical trial of a complex intervention. BMJ Open, 8, e020908. doi: 10.1136/bmjopen-2017-020908 Francis, J., Duncan, E. M., Prior, M. E., MacLennan, G., Dombrowski, S. U., Bellingan, G., Campbell, M. K., Eccles, M. P., Rose, L., Rowan, K. M., Shulman, R., Wilson, A. P. R. and Cuthbertson, B. H. (2014). Selective decontamination of the digestive tract in critically ill patients treated in intensive care units: a mixed-methods feasibility study (the SuDDICU study). Health Technology Assessment, 18(25), doi: 10.3310/hta18250 Mouncey, P. R., Wade, D., Richards-Belle, A., Sadique, Z., Wulff, J., Grieve, R., Emerson, L. M. ...
The newborn check is completed to confirm the fitness of a baby for discharge and to screen for congenital abnormalities, specifically, developmental dysplasia of the hip, congenital cataracts, cryptorchidism and congenital heart disease (CHD).1. In 2005, a Health Technology Assessment (HTA) review of newborn screening for CHD concluded that the current system performs poorly, but that pulse oximetry screening may provide a promising adjunct to clinical examination alone. In the HTA model, only 32% of babies with life-threatening CHD would be diagnosed by clinical examination alone.2. There is good evidence to explain why the routine newborn examination is suboptimal in identifying all cases of CHD. Half the babies in the postnatal ward with CHD have no distinctive murmur, while cyanosis may be difficult to detect clinically, particularly in non-Caucasian ethnic groups.3. In a study of infants with life-threatening CHD from 1984 to 2004, 8% of … ...
Percutaneous transjugular portosystemic shunt. Diagnostic and therapeutic technology assessment (DATTA). Transjugular intrahepatic portosystemic shunt (TIPS): diagnostic and therapeutic technology assessment (DATTA)
TY - JOUR. T1 - Screening for hyperglycaemia in pregnancy. T2 - A rapid update for the National Screening Committee. AU - Waugh, Norman. AU - Royle, Pamela. AU - Clar, Christine. AU - Henderson, Robert. AU - Cummins, Ewen. AU - Hadden, Daniel James. AU - Lindsay, Robert Forrest. AU - Pearson, Donald William MacIntyre. N1 - Crown Copyright © 2010. Published by Elsevier Ltd. All rights reserved.. PY - 2010/9. Y1 - 2010/9. U2 - 10/3310/hta14450. DO - 10/3310/hta14450. M3 - Article. C2 - 20832736. VL - 14. SP - 1. EP - 183. JO - Health Technology Assessment. JF - Health Technology Assessment. SN - 1366-5278. IS - 45. ER - ...
A systematic literature search is conducted in the medical electronic databases MEDLINE, EMBASE, SciSearch etc. in June 2009 and is restricted to the languages German or English. The evaluation includes only published data. The selection of the relevant publications has been performed by two independent reviewers, both experienced in evidence-based medicine procedures.. The analysis includes publications which describe and/or evaluate clinical data from randomized controlled trials (RCT), systematic reviews of RCT, registers of endoprostheses or databases concerning interventions to prevent infections after knee arthroplasty. Only interventions with the explicit objective to decrease the rate of infections after knee arthroplasty (i. e. no blood transfusion etc.) are defined as interventions to prevent infections.. Additionally, a hand search in the reference lists of the relevant articles as well as on the web pages of joint endoprostheses registers (e. g. annual reports) has been conducted ...
1Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria, 2Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA, 3RTI Health Solutions, RTI International, Durham, NC, USA, 4UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria. Department of Health Policy and Management, Harvard T.H. Chan School of Public Health. Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA ...
The New Jersey State Library is sponsoring a twelve-library pilot initiative of the Urban Libraries Councils Edge 2.0 management tool. This past spring, ULC informed the State Library about an opportunity to appraise the newly upgraded Edge tool in a national assessment. Of the 48 New Jersey libraries that ULC invited, 11 participated. The State Library invited the participating libraries to also take part in the pilot project. In the interest of balancing size, type, and geographical distribution, the State Library also invited several libraries that had previously expressed interest in community technology assessment and the earlier version of Edge.. Edge 2.0 enables public libraries to assess their current technology services and review comparison reports. Libraries will have the ability to see how their services compare to state and regional libraries that serve similar communities and have similar-sized budgets. The management tool will also help libraries identify opportunities to better ...
HTIHealth TechnologyHealth Technology and InformaticsDepartment of Health Technology and Informatics醫療科技醫療科技及資訊學系BioinformaticsMedical ImagingMIRadiation TherapyRTRadiation ScienceRadiographyRADMIRS醫療影像放射治療放射科學放射學放射Biomedical ScienceMedical LaboratoryMedical Laboratory ScienceMLSPathologyClinical ChemistryHaematologyMicrobiologyVirology化驗醫療化驗醫療化驗科學BScBachelorUndergraduate學士MScMasterPostgraduate碩士DoctorDoctoral博士研究生MPhilPhDResearch研究CancerGenomicsDiseaseMicrobial InfectionHealthy AgingMetabolicVascular香港理工大學理大理工PolyUPolytechnicPolytechnic University HTI PolyU HTI Health Technology Health Technology and Informatics Department of Health Technology and Informatics 醫療科技 醫療科技及資訊學系 Bioinformatics Medical Imaging MI Radiation Therapy RT Radiation Science Radiography RAD BScRAD MIRS MScMIRS
OBJECTIVES: Health technology assessment (HTA) agencies assessing the cost-effectiveness of healthcare technologies seek evidence from economic evaluations. As well as searching economic evaluation databases, researchers often search MEDLINE and EMBASE, using search filters whose current performance is unclear. We assessed the performance of search filters in identifying economic evaluations from MEDLINE and EMBASE. METHODS: A gold standard of economic evaluations was compiled from National Health Service Economic Evaluation Database (NHS EED) records for 2000, 2003, and 2006. Corresponding records were retrieved in MEDLINE and EMBASE. Search filters were identified from the InterTASC Information Specialists SubGroup Web site and from Canadian Agency for Drugs and Technologies in Health (CADTH) Information Services. The sensitivity and precision of search filters in retrieving gold standard records from MEDLINE and EMBASE were tested. RESULTS: A total of 2,070 full economic evaluations were ...
This is a list of the published NICE technology appraisals. Technology appraisals are recommendations on the use of new and existing medicines and treatments within the NHS ...
Title: Diagnosis and Treatment of Impotence.. Agency: Agency for Health Care Policy and Research/Center for Health Care Technology (Formerly, the Office of Health Technology Assessment).. Contact: Harry Handelsman, D.O., Medical Officer; Thomas V. Holohan, M.D., Director, CHCT.. Status: Technology Assessment: Published, 1990.. Language: English.. Primary Objective: Scientific evaluation of current diagnostic and therapeutic interventions for the management of impotence for the Health Care Financing Administrations Medicare coverage policy.. Methods Used: Synthesis of published literature and information solicited from professional societies and organizations with interest or experience with these technologies.. Data Identification: English language journal articles and textbooks published between 1977 and 1988 available through the search capabilities of the National Library of Medicine. Key words: Impotence; diagnosis; treatment, Erectile dysfunction.. Study Selection: 170 citations of studies ...
MEDLINE, CINAHL, EMBASE/Excerpta Medica, Cochrane Central Register of Clinical Trials, National Research Register, the National Health Service Trusts Clinical Trials Register, Medical Research Council U.K. database, National Health Service Research and Development Health Technology Assessment Programme, and British Heart Foundation database (last search in November 2004 ...
The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic.
My interests centre around health technologies in health systems.. This includes methodologies for the assessment of technologies, conduct of comprehensive health technology assessments (HTA), the study of processes for decision making on the coverage and reimbursement of new technologies and technology-based health services, and the role of public or social values in resource allocation decision-making.. The methods I use include both qualitative and quantitative techniques, and cover both primary and secondary data collection and synthesis. For me, it is essential that such research be conducted in close collaboration with decision making bodies, and therefore I have established good relationships with governments, government agencies and health delivery bodies across Canada.. Degrees. MHSA, University of Alberta, ...
Professor Marion Campbell is inducted as a Fellow of the Society for Clinical Trials (SCT) (http://www.sctweb.org/public/about/fellow.cfm?id=79). 2011: Professor John Norrie appointed as CHaRT Director (Professor Jen Burr steps down as CHaRT Director).. Aberdeen Health Technology Assessment (HTA) Group launched to undertake Evidence Syntheses for the NIHR HTA programme and NICE. Another successful CSO Review with the Unit being congratulated on its outstanding performance over the previous five years.. 2008: Professor Jen Burr appointed as CHaRT Director (Professor John Norrie steps down as CHaRT Director).. The Health Services Research return in the national research assessment exercise (RAE2008) is the highest scoring return for the University of Aberdeen and is joint top of the UK table in health services research. RAE confirmed that 80% of the research submitted was judged as internationally excellent/world class, with 100% of work identified as of international quality.. HSRU celebrates ...
This research was carried out in accordance with HIQAs guidelines for the conduct of health technology assessments. The Terms of Reference of the HTA were agreed between HIQA and the Department of Health. An Expert Advisory Group was convened, with representation from health policy decision-makers, clinicians, patient advocates, professional bodies and experts in health services research and economic evaluation. An Evaluation Team was appointed comprising HIQA staff.. Smoking cessation interventions that are routinely available and used in Ireland were identified and described. A comprehensive review of the safety of these interventions was undertaken, along with a systematic review and network meta-analysis of the available evidence on the clinical effectiveness of smoking cessation interventions among a general population of adult smokers, users of secondary mental health services (defined as inpatient, residential and long-term care for serious mental illness in hospitals, psychiatric and ...
BACKGROUND: A major determinant in cardiovascular disease (CVD) is stress. As transcendental meditation (TM) is thought to help in lowering negative stress indicators, it may be a beneficial strategy for the primary prevention of CVD. OBJECTIVES: To determine the effectiveness of TM for the primary prevention of CVD. SEARCH METHODS: We searched the following electronic databases: the Cochrane Central Register of Controlled Trials (CENTRAL) (2013, Issue 10); MEDLINE (Ovid) (1946 to week three November 2013); EMBASE Classic and EMBASE (Ovid) (1947 to week 48 2013); ISI Web of Science (1970 to 28 November 2013); and Database of Abstracts of Reviews of Effects (DARE) and Health Technology Assessment Database and Health Economics Evaluations Database (November 2013 ...
Mentor: Assist. prof. Nikoleta Leventi, Assist. prof. Stamatios Priftis, Assist. prof. Svetlin Georgiev. Description: The introductory first part will cover the basics of a Health Technology Assessment (HTA) procedure. It will provide core knowledge and understanding of HTA, the interdisciplinary approach needed in order to assess whether a technology works, how much should get reimbursed and under which conditions. Also, the workshop will provide a clear link between HTA and Health Policy - how HTA can affect the physicians practice and patients health. The advanced second part will provide the attendants with the opportunity to perform a mini-HTA on one of the hottest new topics in Medicine - 3D Printed Implantable Medical Devices. ...
Background. Given its high impact on the healthcare service, the management of breast cancer is a relevant issue for all European Union (EU) countries. The three tests assessed in this core health technology assessment (HTA)- uPA/PAI-1 (FEMTELLE®, American Diagnostica) based on immunostaining techniques and MammaPrint® (Agendia) and Oncotype DX® (Genomic Health), based on gene expression profiling-measure multiple markers within the tumour that may indicate how the tumour is likely to develop. The potential clinical utility of the tests lies in their ability to discriminate between patients who will benefit to a greater or lesser extent from a therapeutic intervention. The assessment of technologies of this type could be of interest to all the EU member states.. The uPA/PAI-1, MammaPrint and Oncotype DX tests are intended to predict the likelihood of breast cancer recurrence in women and to support the tailoring of treatment to the individual patient, which may reduce the number of women ...
Currently she holds a chair on Public Health Technology Assessment at the Maastricht University, department of Health Services Research at the Faculty of Health, Medicine and Life Science and at the Care and Public Health Research Institute (Caphri) and at the Netherlands School of Primary Care Research (CaRe). Next to that she is working at the Trimbos Institute, the Centre of expertise on mental health and addiction in the field of HTA research since 2013.. She is involved as an HTA-project leader and supervisor in numerous (clinical) trials funded both nationally (ZonMw, NWO, industry, etc) and internationally (EU, OECD). She is a co-ordinator and a senior lecturer in HTA and Health Economic courses, especially in Health Science Research Master (HSRM) and in the Master Healthcare Policy, Innovation and Management (HPIM). Currently, she has been the co-supervisor of more than 25 PhD. students and about 150 Bachelor and Master students. She has co-authored over 250 publications (Hirsch Index = ...
Sam joined the School of Pharmacy in July 2012. She has developed a comprehensive research program focussed on pharmacoepidemiology - the use of medicines in populations. She has worked with an extensive network of clinicians and health professionals to investigate the use of medicines and adverse effects in cancer, psychiatry, neurology, internal medicine, and general practice. Sam is also involved in research projects with economic evaluations and health technology assessment (HTA). She has an active interest in health systems and health services research, with a particular focus on low and middle income countries (LMIC) and non-communicable diseases (NCD). Sam coordinates, lectures, and tutors in courses in the BPharm (Hons) program and is an advisor for diverse PhD projects. Sam completed a B Science (Hons I) at the University of Queensland then a PhD in fetal physiology at Monash University in Melbourne. After a Sydney Segal Postdoctoral Fellowship at the Samuel Lunenfeld Research Institute ...
Windle, G. (2012) Participation in community arts for health and well-being of people with dementia, their carers, and the communities in which they live - implications for research, policy and practice. In: British Society of Gerontology 41st Annual Conference, Keele, 11th-13th July 2012. Windle, G. and Bennett, K.M. (2012) Caring relationships: How to promte resilience in challenging times. In: The Sociol Ecology of Resilience: A Handbook of Theory and Practice. Springer, pp. 219-232. ISBN 9781461405856 Woods, R.T. and Bruce, E. and Edwards, R.T. and Elvish, R. and Hoare, Z. and Hounsome, B. and Keady, J. and Moniz-Cook, E.D. and Orgeta, V. and Orrell, M. and Rees, J. and Russel, I.T. (2012) REMCARE: reminiscence groups for people with dementia and their family caregivers - effectiveness and cost-effectiveness pragmatic multicentre randomised trial. Health Technology Assessment, 16 ((48)). pp. 1-121. DOI: 10.3310/hta16480 ...
Wednesday 12 July 2017. A University of Salford researcher is part of a team who have been awarded £1.8m as part of a study to tackle rheumatoid arthritis.. Dr Anita Williams has joined the team which is led by Professor Martijn Steultjens and Dr Gordon Hendry at Glasgow Caledonian University with other partners being Keele University,Kings College London and the University of Glasgow and has been awarded funding by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme.. The five year study aims to examine the effectiveness of a new way of improving and maintaining walking ability inpeople who suffer from the painful and disabling symptoms of early rheumatoid arthritis.. Rheumatoid arthritis is a chronic autoimmune disease that attacks multiple joints throughout the body. More than 90% of people with rheumatoid arthritis develop symptoms in the foot and ankle,with resulting difficulties in walking. Many people with rheumatoid arthritis are unable to ...
https://www.researchgate.net/publication/327065544. Abstract. Background: With impending marijuana legislation in Canada, a broad understanding of the harms associated with marijuana use is needed to inform the clinical community and public, and to support evidence-informed public policy development. The purpose of the review was to synthesize the evidence on adverse health effects and harms of marijuana use.. Methods: We searched MEDLINE, The Cochrane Database of Systematic Reviews, Embase, PsycINFO, the Cumulative Index to Nursing and Allied Health Literature, and the Health Technology Assessment Database from the inception of each database to May 2018. Given that systematic reviews evaluating one or other specific harm have been published, this is an overview review with the primary objective of assessing a health effect or harm. Data on author, country and year of publication, search strategy and results, and outcomes were extracted. Quality was assessed using the AMSTAR (A Measurement Tool ...
Alberta Ambassador Program Team, Barton, P., Harstall, C., Moga, C., Rashiq, S., Schopflocher, D., Scott, N.A., & Taenzer, P. (2007). Creating clinically relevant knowledge from systematic reviews: The challenges of knowledge translation. Journal of Evaluation in Clinical Practice, 13(4), 681-8. PMID: 17683314 ABSTRACT: RATIONALE AND OBJECTIVE: A research translation strategy for chronic pain was developed that has significant potential to advance the usefulness of systematic reviews (SRs) in clinical practice. METHOD: The strategy used interactive case-based workshops that summarize current evidence on treatments for chronic non-cancer pain. Health technology assessment researchers and clinicians collaborated to translate SR evidence into education aids, but this proved far from straightforward. RESULTS: Sourcing and selecting the SR evidence required maintaining a credible balance between the diametrical concepts of comprehensiveness and efficiency, and relevance and validity. On examination ...
Background Quality-adjusted Time Without Symptoms of disease and Toxicity (Q-TWiST) survival analysis where time without disease progression is rewarded while time without disease progression but with toxicities is penalized by applying a utility weight is increasingly common in health technology assessments of cancer treatments. AIM: We assess womens preferences for health states specific to advanced stage breast cancer including a baseline diagnoses of ABC, treatment response, no treatment response but no disease progression, disease progression and hormonal therapy specific toxicities.. Method Using FACT-B quality of life data from a randomized clinical trial in ABC univariate statistics were obtained for each item for each health state without regard to treatment. These item scores were paired to the actual narrative in the FACT-B to construct health state narratives consisting of physical, social, emotional, functional well-being and additional concerns content domains. The order of the ...
The design of health technologies relies on assumptions that affect how they will be implemented, such as intended use, complexity, impact on user autonomy, and appropriateness. Those who design and implement technologies make several ethical and social assumptions on behalf of users and society more broadly, but there are very few tools to examine prospectively whether such assumptions are warranted and how the public define and appraise the desirability of health innovations. This study protocol describes a three-year study that relies on a multimedia-based prospective method to support public deliberations that will enable a critical examination of the social and ethical issues of health technology design. The first two steps of our mixed-method study were completed: relying on a literature review and the support of our multidisciplinary expert committee, we developed scenarios depicting social and technical changes that could unfold in three thematic areas within a 25-year timeframe; and for each
The leader in this effort is a new industry lobbying group, the Partnership to Improve Patient Care (dont you love these names, picked to entirely obfuscate what they are really about? It does sound a lot better than the Partnership to Maintain our Profits, a name that would fit it, and indeed virtually all of these lobbying groups). Its spokesman is former California congressman Tony Coelho, a former Democratic whip. He is former because he resigned in the wake of a junk-bond investment scandal. So it is certainly not surprising to see him fronting for such a group; he is well-paid, we can be sure. One of the bugbears raised by these opponents is the British governments National Institute for Clinical Effectiveness (NICE). (Now isnt that a nice name?) NICE evaluates the clinical effectiveness of various interventions and also associates them with a price tag - how much will it cost to treat enough people that one person will have an improvement of a certain amount of quality life ...
Bedson, E., Bell, D., Carr, D., Carter, B., Hughes, D., Jorgensen, A., Lewis, H., Lloyd, K., McCaddon, A., Moat, S., Pink, J., Pirmohamed, M., Roberts, S., Russell, I., Sylvestre, Y., Tranter, R., Whitaker, R., Wilkinson, C. & Williams, N. (2014). Folate Augmentation of Treatment - Evaluation for Depression (FolATED): randomised trial and economic evaluation. Health Technology Assessment 18(48), 1-160. ...
ABJHI is helping an Alberta research team design the optimal centralized intake system for osteoarthritis and rheumatoid arthritis sufferers in Alberta. The centralized intake is being designed to reduce the wait for care and ensure Albertans are referred to the right health care provider at the appropriate time.. The project involves nearly 40 researchers led by Drs. Deborah Marshall and Linda Woodhouse. Dr. Marshall is the Canada Research Chair of Health Services and Systems Research and ABJHIs Director of Health Technology Assessment. Dr. Woodhouse holds the David Magee Endowed Chair in Musculoskeletal Health and is the Scientific Director of Alberta Health Services Bone and Joint Health Strategic Clinical Network.. ABJHI is managing the data for the research project, which is funded by a grant from the Partnership for Research and Innovation in the Health System. The researchers will set out performance objectives for the new centralized intake model. They will analyze different central ...
Resumo: BACKGROUND: The projected rise in the incidence of type 2 diabetes mellitus (T2DM) could develop into a substantial health problem worldwide. Whether insulin secretagogues (sulphonylureas and meglitinide analogues) are able to prevent or delay T2DM and its associated complications in people at risk for the development of T2DM is unknown. OBJECTIVES: To assess the effects of insulin secretagogues on the prevention or delay of T2DM and its associated complications in people with impaired glucose tolerance, impaired fasting blood glucose, moderately elevated glycosylated haemoglobin A1c (HbA1c) or any combination of these. SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials, MEDLINE, PubMed, Embase, ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform, and the reference lists of systematic reviews, articles and health technology assessment reports. We asked investigators of the included trials for information about ...
From a systematic review and evidence map to addressing evidence gaps regarding maternal injuries after vaginal birth - Marie Österberg, PhD, Christel Hellberg, Dr. Msc. View presentation.. Defining ranges for certainty ratings of diagnostic accuracy - Monica Hultcrantz. View presentation.. Effects and experiences of pharmacological interventions in forensic psychiatry - a health technology assessment - Monica Hultcrantz. View presentation. ...
Established in 1994 ScHARRs Information Resources team has established itself as a key national player in providing information support to health technology assessment and health services research. The team is made up of professional, highly trained Information Specialists who are involved in the forefront of research, teaching, support and development. This is our blog where we talk about the diverse work we do: #Teach #Research #Search #Support. ...
Because a variety of outcome measures were used, the authors decided against performing a meta- analysis and opted instead for a qualitative analysis. For example, people with dry AMD usually develop vision loss very slowly over a period of many years. It originates from the inferioris vertebral spine in the middle and lower back and covers the lower half of the Mentalis thoracic region, forming the posterior portion of the axilla (armpit). REFERRING PATIENTS FOR ACUPUNCTURE TREATMENT It is important to distinguish the difference between disease and illness. A speech therapist and high-tech aids such as computer- This nurse is taking a girl with cerebral palsy for a walk in controlled communication devices, can make a tremen- her motorized wheelchair. MECHANISMS We will use the term expectancy as used in a recent Health Technology Assessment 11 monograph concerning the role of expectancies in the placebo effect. Survival rates five years after pancre- atic cancer generic caverta 50mg otc, in ...
ODonnell, A., McParlin, C., Robson, S. C., Beyer, F., Moloney, E., Bryant, A., Bradley, J., Muirhead, C., Nelson-Piercy, C., Newbury-Birch, D., Norman, J., Simpson, E., Swallow, B., Yates, L. & Vale, L., 1 Oct 2016, In : Health Technology Assessment. 20, 74, p. vii-268. Research output: Contribution to journal › Article ...
In a recent study published in Health Technology Assessment, the risks and benefits of daily aspirin were assessed, showing that healthy people without risk of cardiovascular events should not take aspirin daily.
Sexual health technologies in context Dr Mark Davis School of Political and Social Inquiry School of Population Health Seminar The University of Queensland Tuesday 9 July 2013. Overview. More on sexual health technologies Social, economic and technological factors Slideshow 3359227 by parker
Joseph Pliskin is the Sidney Liswood Professor of Health Care Management at Ben-Gurion University of the Negev. He is a member of the Department of Industrial Engineering and Management and of the Department of Health Systems Management. Dr. Pliskin also has an appointment as an Adjunct Professor at the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health.. Dr. Pliskins research interests focus on clinical decision making, operations management in health care organizations, cost-benefit and cost-effectiveness analysis in health and medicine, technology assessment, utility theory and decision analysis.. He has published extensively on issues relating to end stage renal disease, heart disease, Down syndrome, technology assessment and methodological issues in decision analysis. He is co-author of a recent book Decision Making in Health and Medicine: Integrating Evidence and Values (Cambridge University Press, Cambridge UK, 2001), and is working on a new book ...
The general framework of this thesis is that of ethical Technology Assessment (eTA). Whereas the first essay proposes an inclusive approach to technology assessment by delineating an ethical checklist, the following essays focus on two of the checklist points, i.e. privacy and control, influence and power, in relation to workspace surveillance.. The core idea of Essay I (written in collaboration with Sven Ove Hansson) is that, due to its strong social impact, new technology and novel use of existing technology should be considered from the perspective of ethics. We suggest that assessments should be conducted on the basis of nine crucial ethical aspects of technology.. In Essay II an in-depth analysis of the meaning and value of privacy in the realm of work is undertaken. The meaning and value of privacy is explained as well as why it should be protected. It is argued that two dimensions of privacy should be safeguarded; informational privacy and local privacy for the reason that ...
This report is based on research conducted by the Tufts-New England Medical Center Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0022). The findings and conclusions in this document are those of the authors who are responsible for its contents. The findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of the Agency for Healthcare Research and Quality or of the U.S. Department of Health and Human Services.. The information in this report is intended to help health care decision-makers; patients and clinicians, health system leaders, and policymakers, make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Decisions concerning the provision of clinical care should consider this ...
The use of energy technologies is often associated with impacts on human health and environment. The goal of environmental impact assessment is the modeling and quantification of these effects. Not only the direct emissions from the operating system (e.g. the power plant, or the vehicle) have to be considered, but also impacts that arise from the life cycle of the system (e.g. the fuel production, the vehicle production, the impacts of roads and other infrastructure, etc.).
Read chapter 3 Assessment of LED and OLED Technologies: The standard incandescent light bulb, which still works mainly as Thomas Edison invented it, conve...
A visit was made to Jay Instruments and Specialties Company, Cincinnati, Ohio to evaluate control measures for mercury (7439976) exposure. Major renovations in this facility included the erection of a partial wall, the installation of ventilation controls, changes in processing equipment, and modifications of work stations. To reduce mercury vaporization in the thermometer fill room, two air condi
Tomosynthesis produces three-dimensional images of an object, with non-isotropic resolution. Tomosynthesis images are typically read by human observers in a stack viewing mode, displaying planes through the tomosynthesis volume. The purpose of this study was to investigate whether human performance in a signal-known exactly (SKE) detection task improves when the entire tomosynthesis volume is available to the observer, compared to displaying a single plane through the signal center. The goal of this study was to improve understanding of human performance in order to aid development of observer models for tomosynthesis. Human performance was measured using sequential 2-alternative forced choice experiments. In each trial, the observer was first asked to select the signal-present ROI based on a single 2D tomosynthesis plane. Then, scrolling was enabled and the observer was able to select the signal-present ROI, based on knowledge of the entire volume. The number of correct decisions for 2D and 3D ...
TY - JOUR. T1 - Management of chronic hepatitis C.. AU - Gebo, K. A.. AU - Jenckes, M. W.. AU - Chander, G.. AU - Torbenson, M. S.. AU - Ghanem, K. G.. AU - Herlong, H. F.. AU - Sulkowski, M. S.. AU - El-Kamary, S. S.. AU - Harris, K. A.. AU - Guedelhoefer, O. C.. AU - Bass, E. B.. PY - 2002/6. Y1 - 2002/6. UR - http://www.scopus.com/inward/record.url?scp=0036594570&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=0036594570&partnerID=8YFLogxK. M3 - Article. C2 - 12187570. AN - SCOPUS:0036594570. SP - 1. EP - 7. JO - Evidence report/technology assessment (Summary). JF - Evidence report/technology assessment (Summary). SN - 1530-440X. IS - 60. ER - ...
Bjorn Christ, President - HemoCue AB and Deepak Sharma, Regional Sales Director Asia Pacific, HemoCue, in conversation with Ekta Srivastava, Health technology talks about on how to Screen and Treat Anemia and the potentiality of technology in eradicating anemia. Current state of anemia in India and how it needs to be tackled. Affecting over half of all Indian women, a fourth of all men, 79% of children aged 6-59 months and causing 20 per cent maternal deaths, anemia presents a formidable public health challenge. Seeing the magnitude of the problem, there is a dire need to take urgent steps to ensure anemia is diagnosed in time and treatment measures instituted promptly.. Emphasis on anemia in pregnant women and issues related. With formidable statistics in women and pregnant women, anemia and its related complications can have very serious implications on the health of this and coming generations. An anaemic mother will give birth to a weak child who will be more susceptible to diseases. Hence, ...
Detailed information regarding the technology appraisals programme is available elsewhere (http://www.nice.org.uk/). Briefly, after receiving the final scope of the appraisal (the scope document outlines the patients, interventions, comparator technology, and outcomes of interest) from NICE, consultees have about 15 weeks to submit relevant clinical and economic evidence. During, and for a short period after, this time, the assessment group also undertakes its independent assessment of the clinical and economic evidence.. The appraisals committee meets twice to discuss the evidence. After the first meeting, the committees preliminary recommendations are outlined in a document called the appraisal consultation document. At the second meeting, consultees comments on this document are discussed and a final appraisal determination is produced. If consultees do not appeal against it, this document becomes the basis of NICE guidance.. Each manufacturer and the assessment group typically submit an ...
Detailed information regarding the technology appraisals programme is available elsewhere (http://www.nice.org.uk/). Briefly, after receiving the final scope of the appraisal (the scope document outlines the patients, interventions, comparator technology, and outcomes of interest) from NICE, consultees have about 15 weeks to submit relevant clinical and economic evidence. During, and for a short period after, this time, the assessment group also undertakes its independent assessment of the clinical and economic evidence.. The appraisals committee meets twice to discuss the evidence. After the first meeting, the committees preliminary recommendations are outlined in a document called the appraisal consultation document. At the second meeting, consultees comments on this document are discussed and a final appraisal determination is produced. If consultees do not appeal against it, this document becomes the basis of NICE guidance.. Each manufacturer and the assessment group typically submit an ...
Download POGIL College of Health Technology Past Questions and Answers for Entrance Examination are available in PDF format. You can download and print it